PledPharma AB | Innovative, unique and integrated competence in pharmaceutical drug development with focus on improving treatments for severe diseases with substantial unmet medical need where alternative treatments does not exist

PledPharma has an innovative, unique and integrated competence in pharmaceutical drug development with focus on improving treatments for severe diseases with substantial unmet medical need where alternative treatments doesn’t exist.

PledPharma in the media

Redeye research: Aladote upside

Pipeline

The Penser Corporate Day

Go to the link

Press Releases

June 26, 2020

Positive pre-clinical results with PledOx to be presented at Peripheral Nerve Society’s annual meeting

Regulatory

June 24, 2020

Marie-Louise Alamaa appointed interim CFO at PledPharma

Regulatory

May 26, 2020

CFO Yilmaz Mahshid leaves PledPharma

Latest Report

April 22, 2020

Latest interim report

March 30, 2020

Annual report 2019 (in Swedish)

Latest presentation

June 4, 2020

The Penser Corporate Day

Calendar and upcoming reports

June 8-12

BIO One-on-One Partnering™

August 20, 2020

Interim report second quarter 2020

November 4, 2020

Interim report third quarter 2020

Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@pledpharma.com